Red blood cell supernatant potentiates LPS-induced proinflammatory cytokine response from peripheral blood mononuclear cells.
Allogeneic blood transfusion has an immunomodulatory capacity on its recipients through accumulation of immunologically active substances with blood storage, and prestorage leukoreduction reduces many of these mediators. We investigated lipopolysaccharide (LPS)-induced cytokine response of peripheral blood mononuclear cells (PBMCs) exposed to packed red blood cell (PRBC) supernatants from leukoreduced (LR) or non-leukoreduced (NLR) units with variable duration of storage. PRBC units were collected with or without leukoreduction on Day 0 before routine storage. The plasma fraction (supernatant) was isolated from LR and NLR units after 1 day (D1) or 42 days (D42) of storage and exposed to PBMCs versus control media for 24 h, then with LPS for an additional 24 h. Cell supernatants were analyzed for IL-1beta, IL-6, IL-8, IL-10, and TNF-alpha by cytokine bead array. IL-1beta, TNF-alpha, and IL-6 were significantly elevated in PRBC groups versus control. D42 NLR PRBC supernatant significantly increased secretion of IL-1beta and IL-6 compared to D1 NLR PRBC supernatant. LR significantly attenuated the cytokine response of IL-1beta. Thus, PRBC supernatant potentiates proinflammatory LPS-induced cytokine secretion from PBMCs. This response is accentuated with storage duration and partially attenuated with leukoreduction. These findings may partially explain the immune activation seen clinically after blood transfusion.
Baumgartner
Joel M
JM
Department of Surgery, University of Colorado, Denver, Aurora, CO 80045, USA. joel.Baumgartner@uchsc.edu
Nydam
Trevor L
TL
Clarke
Jason H
JH
Banerjee
Anirban
A
Silliman
Christopher C
CC
McCarter
Martin D
MD
D001793:Blood Preservation; D001803:Blood Transfusion; D017690:Cell Transplantation; D016207:Cytokines / Q000378:metabolism*; D004912:Erythrocytes / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism*; D007963:Leukocytes, Mononuclear / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D008070:Lipopolysaccharides / Q000378:metabolism; D008213:Lymphocyte Activation; D008212:Lymphocyte Depletion; D019899:Paracrine Communication / Q000276:immunology; D013997:Time Factors; D015854:Up-Regulation; D014947:Wounds and Injuries / Q000276:immunology* / Q000628:therapy
D016207:Cytokines; D018836:Inflammation Mediators; D008070:Lipopolysaccharides